Search research articles
Contact Us
Filters
Showing results (161-170 of 460) with videos related to
Page
of 46
Sort By:
Transplantation and Cellular Therapy
|
June 7, 2022
ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy
Nausheen Ahmed, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.
Transplantation and Cellular Therapy
|
September 21, 2020
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation
Narendranath Epperla, Kwang W Ahn, Manoj Khanal, et al.
Blood Advances
|
September 6, 2019
HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis
Mohamad A Meybodi, Wenhao Cao, Leo Luznik, et al.
American Journal of Hematology
|
September 7, 2022
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells
Joanna C Zurko, Timothy S Fenske, Bryon D Johnson, et al.
Blood Cancer Journal
|
July 31, 2019
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
Binod Dhakal, Anita D'Souza, Mehdi Hamadani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2017
Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation
Jonathan T Kapke, Narendranath Epperla, Namrata Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 13, 2020
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma
Kathleen Monahan, Ariel Kleman, Bicky Thapa, et al.
Haematologica
|
August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study
Leo I Gordon, Fei Fei Liu, Julia Braverman, et al.
JAMA Oncology
|
January 6, 2018
Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis
Binod Dhakal, Aniko Szabo, Saurabh Chhabra, et al.
Leukemia & Lymphoma
|
December 30, 2009
Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma
Don M Benson, Kathryn Panzner, Mehdi Hamadani, et al.
Page
of 46
Search research articles
Search
Showing results (161-170 of 460) with videos related to
Sort By:
Page
of 46
Transplantation and Cellular Therapy
|
June 7, 2022
ASTCT Committee on Practice Guidelines Survey on Evaluation & Management of Diffuse Large B-cell Lymphoma after Failure of Chimeric Antigen Receptor T Cell Therapy (CAR-T) Therapy
Nausheen Ahmed, Ambuj Kumar, Mohamed A Kharfan-Dabaja, et al.
Transplantation and Cellular Therapy
|
September 21, 2020
Impact of Reduced-Intensity Conditioning Regimens on Outcomes in Diffuse Large B Cell Lymphoma Undergoing Allogeneic Transplantation
Narendranath Epperla, Kwang W Ahn, Manoj Khanal, et al.
Blood Advances
|
September 6, 2019
HLA-haploidentical vs matched-sibling hematopoietic cell transplantation: a systematic review and meta-analysis
Mohamad A Meybodi, Wenhao Cao, Leo Luznik, et al.
American Journal of Hematology
|
September 7, 2022
Long-term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T-cells
Joanna C Zurko, Timothy S Fenske, Bryon D Johnson, et al.
Blood Cancer Journal
|
July 31, 2019
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
Binod Dhakal, Anita D'Souza, Mehdi Hamadani, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
August 1, 2017
Effect of Routine Surveillance Imaging on the Outcomes of Patients With Classical Hodgkin Lymphoma After Autologous Hematopoietic Cell Transplantation
Jonathan T Kapke, Narendranath Epperla, Namrata Shah, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 13, 2020
Propylene Glycol-Free Melphalan versus PG-Melphalan as Conditioning for Autologous Hematopoietic Cell Transplantation for Myeloma
Kathleen Monahan, Ariel Kleman, Bicky Thapa, et al.
Haematologica
|
August 30, 2023
Lisocabtagene maraleucel for second-line relapsed or refractory large B-cell lymphoma: patient-reported outcomes from the PILOT study
Leo I Gordon, Fei Fei Liu, Julia Braverman, et al.
JAMA Oncology
|
January 6, 2018
Autologous Transplantation for Newly Diagnosed Multiple Myeloma in the Era of Novel Agent Induction: A Systematic Review and Meta-analysis
Binod Dhakal, Aniko Szabo, Saurabh Chhabra, et al.
Leukemia & Lymphoma
|
December 30, 2009
Effects of induction with novel agents versus conventional chemotherapy on mobilization and autologous stem cell transplant outcomes in multiple myeloma
Don M Benson, Kathryn Panzner, Mehdi Hamadani, et al.
Page
of 46